Featured Research

from universities, journals, and other organizations

An Existing Diuretic May Suppress Seizures In Newborns

Date:
November 7, 2005
Source:
Children's Hospital Boston
Summary:
A diuretic drug called bumetanide may serendipitously help treat seizures in newborns, which are difficult to control with existing anticonvulsants, according to a study in the November Nature Medicine. The study findings could lead to clinical trials of bumetanide in newborns, whose immature, rapidly-developing brains are especially vulnerable to seizures that can cause long-term neurologic impairments and a tendency toward seizures later in life.

A diuretic drug called bumetanide may serendipitously help treat seizures in newborns, which are difficult to control with existing anticonvulsants, according to a study in the November Nature Medicine. The study findings could lead to clinical trials of bumetanide in newborns, whose immature, rapidly-developing brains are especially vulnerable to seizures. Newborns' seizures can cause long-term neurologic impairments and a tendency toward seizures later in life.

Conventional anticonvulsants -- phenobarbital and benzodiazepines -- are ineffective in newborns because their brains are biochemically different from adult brains, says neurologist Frances Jensen, MD, of Children's Hospital Boston, a senior investigator on the study. Jensen's team, led by postdoctoral fellow Delia Talos, PhD, collaborated with Kevin Staley and colleagues at the University of Colorado Health Sciences Center to find a treatment for seizures that would work in newborns.

The researchers knew that conventional anticonvulsants work by mimicking the action of GABA, a natural inhibitory chemical in the brain, by activating GABA receptors on the surface of brain cells. In adult nerve cells, GABA activation opens up channels that allow chloride to move into the cell. The cell thereby acquires a negative charge and becomes less excitable, inhibiting seizure activity. But in newborns, chloride is already high, and therefore activating GABA receptors causes chloride to move out of nerve cells, creating a paradoxical excitatory reaction that may actually exacerbate seizures.

To better understand this paradox, the researchers focused on two molecules that regulate cellular chloride levels: KCC2, which transports chloride out of cells, and NKCC1, which brings chloride in. Previous studies in rats had shown that adult nerve cells mostly have KCC2, making their chloride concentrations lower inside than outside. Thus, when GABA receptors are activated, chloride tends to come in, with an inhibitory effect. In newborn rats, the situation is reversed: their nerve cells mostly have NKCC1, so chloride is actively transported inside, making initial chloride concentrations very high. As a result, GABA activation causes chloride to exit the cell, with an excitatory effect.

To see if the same pattern applies in humans, Talos and colleagues at Children's Hospital Boston examined NKCC1 and KCC2 levels in brain tissue from children who had died, ranging from second-trimester fetuses to preschool-age children. Just as in rats, NKCC1 levels were high during the fetal and newborn periods, peaking one week after birth, but fell during the first year of life, approaching the low levels found in adults. Also as in rats, KCC2 levels were initially low, but rose over the first year of life.

"We found that NKCC1 is expressed unopposed in the immature brain," says Jensen. "We thought that perhaps if we blocked its inward transfer of chloride, we could get immature neurons to act like older neurons and give GABA a chance to do what it's supposed to do."

The researchers knew that the diuretic bumetanide inhibits NKCC1 activity in the kidney, and reasoned that the drug might have a similar effect in the brain, lowering chloride levels and making nerve cells responsive to GABA activation. Staley and colleagues in Colorado conducted a trial in baby rats and found that bumetanide indeed inhibited seizure activity, while phenobarbital, as in humans, worked poorly.

The study's findings are in keeping with epidemiologic studies finding that adults taking diuretics for other reasons are less likely to have seizures. Jensen's group has begun discussions about launching a clinical trial of bumetanide in newborns. Although the drug is FDA-approved and has been used in newborns for other indications, a number of safety questions will first need to be addressed before a trial can proceed.

Last year, Jensen's lab found that another FDA-approved drug, topiramate, may prevent long-term seizure disorders in newborns who suffer seizures due to oxygen starvation. This drug acts by blocking another receptor, known as the AMPA glutamate receptor, which is much more abundant in newborns' brains than adult brains (see http://www.childrenshospital.org/newsroom/Site1339/mainpageS1339P1sublevel86.html). Like bumetamide, topiramate targets proteins that are uniquely expressed in the neonatal brain.

"As we learn more about age-specific brain mechanisms, we can develop novel therapies for newborn seizures, but in the meantime, there may be things already on the shelf that we can use," Jensen says.

###

The current study was funded by the National Institute of Neurological Disorders and Stroke and the Hearst Foundation.

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, nine members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 347-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: http://www.childrenshospital.org/research/.


Story Source:

The above story is based on materials provided by Children's Hospital Boston. Note: Materials may be edited for content and length.


Cite This Page:

Children's Hospital Boston. "An Existing Diuretic May Suppress Seizures In Newborns." ScienceDaily. ScienceDaily, 7 November 2005. <www.sciencedaily.com/releases/2005/11/051107083159.htm>.
Children's Hospital Boston. (2005, November 7). An Existing Diuretic May Suppress Seizures In Newborns. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2005/11/051107083159.htm
Children's Hospital Boston. "An Existing Diuretic May Suppress Seizures In Newborns." ScienceDaily. www.sciencedaily.com/releases/2005/11/051107083159.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins